Literature DB >> 10502358

Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging.

C H Tung1, S Bredow, U Mahmood, R Weissleder.   

Abstract

A variety of proteases are overexpressed or activated during pathogenesis and represent important targets for therapeutic drugs. We have previously shown that optical imaging probes sensitive in the near-infrared fluorescence (NIRF) spectrum can be used for in vivo imaging of enzyme activity. In the current study, we show that these probes can be designed with specificity for specific enzymes, for example, cathepsin D which is known to be overexpressed in many tumors. A NIR cyanine fluorochrome served as the optical reporter and was attached to the amino terminal of an 11 amino acid peptide sequence with specificity for cathepsin D. The peptides were subsequently attached to a synthetic graft copolymer for efficient tumoral delivery. The close spatial proximity of the multiple fluorochromes resulted in quenching of fluorescence in the bound state. A 350-fold signal amplification was observed post cleavage during in vitro testing. Cell culture experiments using a rodent tumor cell line stably transfected with human cathepsin D confirmed enzyme specific activation within cells. This sequence but not a scrambled control sequence showed enzyme specificity in vitro. We conclude that activatable NIRF optical probes can be synthesized to potentially probe for specific enzymes in living organisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502358     DOI: 10.1021/bc990052h

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  51 in total

Review 1.  Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents.

Authors:  D J Hawrysz; E M Sevick-Muraca
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

2.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.

Authors:  Alexei A Bogdanov; Charles P Lin; Maria Simonova; Lars Matuszewski; Ralph Weissleder
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

3.  Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Craig D Logsdon; Ching-Hsuan Tung
Journal:  Mol Biosyst       Date:  2011-09-20

4.  Molecular Imaging of Proteases in Cancer.

Authors:  Yunan Yang; Hao Hong; Yin Zhang; Weibo Cai
Journal:  Cancer Growth Metastasis       Date:  2009-08-17

Review 5.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

6.  Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.

Authors:  Zobeida Cruz-Monserrate; Wael R Abd-Elgaliel; Tobias Grote; Defeng Deng; Baoan Ji; Thiruvengadam Arumugam; Huamin Wang; Ching-Hsuan Tung; Craig D Logsdon
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

7.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

Review 8.  Molecular optical imaging: applications leading to the development of present day therapeutics.

Authors:  Khalid Shah; Ralph Weissleder
Journal:  NeuroRx       Date:  2005-04

Review 9.  [Optical imaging of fluorescence in the near infrared. From passive to enzymatically activated contrast medium].

Authors:  M Funovics
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

Review 10.  New strategies for fluorescent probe design in medical diagnostic imaging.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Raphael Alford; Peter L Choyke; Yasuteru Urano
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.